Evidence map›Paper›PMID 39086311›Full record

ReviewTexas Heart Institute journal2024

Modern Perspectives on Hypertrophic Cardiomyopathy-No One Size Fits All.

Brett Doliner, Hadeel Gaddar, Ramsey Kalil, Alexander Postalian

Abstract readReviewCase Reports
In one paragraph

Review in Texas Heart Institute journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Brett DolinerDepartment of Cardiology, The Texas Heart Institute, Houston, Texas.
Hadeel GaddarFaculty of Medicine at the American University of Beirut, Beirut, Lebanon.
Ramsey KalilDepartment of Cardiology, The Texas Heart Institute, Houston, Texas.
Alexander PostalianDepartment of Cardiology, The Texas Heart Institute, Houston, Texas.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite substantial advances in the management of hypertrophic cardiomyopathy, advanced heart failure remains a major cause of morbidity in this patient population. This narrative review presents the case of a patient with hypertrophic obstructive cardiomyopathy who underwent alcohol septal ablation to frame a discussion of modern therapies for hypertrophic cardiomyopathy. The current treatment landscape includes medications, both old and new, and surgical and procedural interventions to relieve mechanical obstruction. Several promising new modalities for relieving obstruction are in the nascent stages of development.

Indexed as

Ablation TechniquesCardiomyopathy, HypertrophicEthanolHumansTreatment OutcomeEthanolablation techniquesCardiomyopathy, hypertrophicradiosurgery

Identifiers

PMID39086311
PMCPMC11292115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.